BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia 2015;179:415-24. [PMID: 25633436 DOI: 10.1007/s11046-015-9864-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kamali Sarwestani Z, Hashemi SJ, Rezaie S, Gerami Shoar M, Mahmoudi S, Elahi M, Bahardoost M, Tajdini A, Abutalebian S, Daie Ghazvini R. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. J Mycol Med 2018;28:279-84. [PMID: 29540288 DOI: 10.1016/j.mycmed.2018.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Kiakojuri K, Mahdavi Omran S, Roodgari S, Taghizadeh Armaki M, Hedayati MT, Shokohi T, Haghani I, Javidnia J, Kermani F, Badali H, Abastabar M. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis. Mycopathologia 2021;186:245-57. [PMID: 33718990 DOI: 10.1007/s11046-021-00537-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Görür K, İsmi O, Özcan C, Vayısoğlu Y. Treatment of Otomycosis in Ears with Tympanic Membrane Perforation is Easier with Paper Patch. Turk Arch Otorhinolaryngol 2019;57:182-6. [PMID: 32128515 DOI: 10.5152/tao.2019.4384] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, Mohammadi R, Sepahvand A. Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis 2017;In Press. [DOI: 10.5812/archcid.57287] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Chadeganipour M, Mohammadi R. A 9-Year Experience of Aspergillus Infections from Isfahan, Iran. Infect Drug Resist 2020;13:2301-9. [PMID: 32765006 DOI: 10.2147/IDR.S259162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Taheri Rizi Z, Abastabar M, Fakhim H, Ilkit M, Ahangarkani F, Javidnia J, Haghani I, Meis JF, Badali H. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates. Mycopathologia 2020;185:357-65. [PMID: 32112265 DOI: 10.1007/s11046-020-00434-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Li Y, He L. Diagnosis and treatment of otomycosis in southern China. Mycoses 2019;62:1064-8. [PMID: 31368588 DOI: 10.1111/myc.12979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Weisshaar E. Itch: A Global Problem? Front Med (Lausanne) 2021;8:665575. [PMID: 34124095 DOI: 10.3389/fmed.2021.665575] [Reference Citation Analysis]
9 Brkic FF, Besser G, Schally M, Schmid EM, Parzefall T, Riss D, Liu DT. Biannual Differences in Interest Peaks for Web Inquiries Into Ear Pain and Ear Drops: Infodemiology Study. J Med Internet Res 2021;23:e28328. [PMID: 34185016 DOI: 10.2196/28328] [Reference Citation Analysis]
10 Kiakojuri K, Armaki MT, Rajabnia R, Pournajaf A, Karami M, Khademian A, Omran SM. Outer Ear Infections in Iran: A Review. Open Access Maced J Med Sci 2019;7:1233-40. [PMID: 31049113 DOI: 10.3889/oamjms.2019.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Gharaghani M, Halvaeezadeh M, Ali Jalaee G, Taghipour S, Kiasat N, Zarei Mahmoudabadi A. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran. Curr Med Mycol 2020;6:18-22. [PMID: 33628977 DOI: 10.18502/CMM.6.2.2696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sabz G, Gharaghani M, Mirhendi H, Ahmadi B, Gatee MA, Sisakht MT, Hemati A, Mohammadi R, Taghavi J, Nouripour-Sisakht S. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent. J Med Microbiol 2019;68:585-90. [PMID: 30801244 DOI: 10.1099/jmm.0.000948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Aboutalebian S, Mahmoudi S, Okhovat A, Khodavaisy S, Mirhendi H. Otomycosis Due to the Rare Fungi Talaromyces purpurogenus, Naganishia albida and Filobasidium magnum. Mycopathologia 2020;185:569-75. [PMID: 32232764 DOI: 10.1007/s11046-020-00439-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
15 Zhang S, Jin M, Hu S, Zhang Y, Zhou G. Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation. Ann Otol Rhinol Laryngol 2021;130:273-9. [PMID: 32772544 DOI: 10.1177/0003489420946783] [Reference Citation Analysis]
16 Tasić-Otašević S, Golubović M, Đenić S, Ignjatović A, Stalević M, Momčilović S, Bojanović M, Arsić-Arsenijević V. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia. J Mycol Med 2020;30:101011. [PMID: 32693980 DOI: 10.1016/j.mycmed.2020.101011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical features. Curr Med Mycol 2017;3:27-30. [PMID: 29707671 DOI: 10.29252/cmm.3.3.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
18 Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M. Role of Clotrimazole in Prevention of Recurrent Otomycosis. Biomed Res Int 2019;2019:5269535. [PMID: 31950041 DOI: 10.1155/2019/5269535] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lee A, Tysome JR, Saeed SR. Topical azole treatments for otomycosis. Cochrane Database Syst Rev 2021;5:CD009289. [PMID: 34033120 DOI: 10.1002/14651858.CD009289.pub2] [Reference Citation Analysis]
20 Sangaré I, Amona FM, Ouedraogo RW, Zida A, Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J Mycol Med 2021;31:101115. [PMID: 33516991 DOI: 10.1016/j.mycmed.2021.101115] [Reference Citation Analysis]
21 Wingelaar TT, van Ooij PA, van Hulst RA. Otitis externa in military divers: more frequent and less harmful than reported. Diving Hyperb Med 2017;47:4-8. [PMID: 28357818 DOI: 10.28920/dhm47.1.4-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]